KIU Publications

Research outputs, reports, policy briefs and knowledge products from KIU scholars and partners.

Scholarly Work

KIU publications archive

Search peer-reviewed articles, reports, books, policy briefs and other scholarly outputs by KIU researchers and collaborators.

Reset
5,563 results found Use the filters to narrow results by title, author, section, publication year or keyword.
2026 School of Pharmacy

Evaluating Hospital Readiness for HIV/AIDS Care: A Comparative Study between Uganda and Nigeria

Abaho Areeba Fortunate

2026 | IAA Journal of Scientific Research | Pp. 124-128

HIV/AIDS remains a significant public health challenge in Sub-Saharan Africa, with Uganda and Nigeria facing high HIV burdens despite efforts to improve care. This review evaluates and compares hospital readiness for HIV/AIDS care in both countries, focusing...

2026 School of Pharmacy

Ethical, Legal, and Social Implications of Polygenic Risk Scores in Primary Care: Consent, Governance, and Trust

Abaho Areeba Fortunate

2026 | IAA Journal of Scientific Research | Pp. 119-123

Polygenic risk scores (PRS) are increasingly promoted as tools for improving disease risk stratification and preventive care in primary healthcare settings. By aggregating the effects of thousands of common genetic variants, PRS offer probabilistic insights i...

2026 School of Pharmacy

Epigenetic Alterations in Obesity-Driven Type 2 Diabetes: Implications for Personalized Medicine

Abaho Areeba Fortunate

2026 | IAA Journal of Scientific Research | Pp. 111-118

Obesity-driven type 2 diabetes (T2D) reflects chronic environmental stress overnutrition, inactivity, and circadian disruption imprinted onto chromatin in metabolic tissues. Epigenetic changes integrate nutrient, hormonal, and inflammatory cues into durable p...

2026 School of Pharmacy

Engineering Nanoparticles to Modulate Gut Microbiota in Obesity-Induced Insulin Resistance

Muhindo Anitah

2026 | IAA Journal of Scientific Research | Pp. 102-110

Obesity-induced insulin resistance emerges from intertwined host–microbe interactions that reshape intestinal permeability, immune tone, and metabolic signaling. Dysbiosis, characterized by reduced microbial diversity, altered short-chain fatty acid productio...

2026 School of Pharmacy

Engineering Glucose-Responsive Nanomaterials for Adaptive Drug Release in Diabetic Obesity Patients

Mukisa Ian Mugaiga

2026 | IAA Journal of Scientific Research | Pp. 92-101

Diabetic obesity, the coexistence of obesity with type 2 diabetes mellitus (T2DM), represents a syndemic condition characterized by chronic hyperglycemia, insulin resistance, low-grade inflammation, and profound pharmacokinetic variability. Conventional antid...

2026 School of Pharmacy

Endothelial Activation Biomarkers in Severe Plasmodium falciparum Malaria Among Patients with Type 1 Diabetes Mellitus

Mukisa Ian Mugaiga

2026 | IAA Journal of Scientific Research | Pp. 83-91

Severe Plasmodium falciparum malaria constituted a life-threatening parasitic infection characterized by widespread endothelial activation, microvascular sequestration, and systemic inflammation. Type 1 diabetes mellitus is associated with baseline endothelia...

2026 School of Pharmacy

Emerging Neuroprotective Strategies Against Oxidative Stress-Induced Neurotoxicity in Systemic Disorders: Lessons from Diabetes, Malaria, and Hepatic Dysfunction

Mutebi Mark

2026 | IAA Journal of Scientific Research | Pp. 78-82

Oxidative stress is a central, converging mechanism underlying neurotoxicity in a broad range of systemic disorders, including diabetes mellitus, malaria, and hepatic dysfunction. In these conditions, excessive reactive oxygen and nitrogen species (ROS/RNS),...

2026 School of Pharmacy

Efficacy of Insecticide-Treated Nets and Community Strategies in Malaria Prevention during Pregnancy

Mutebi Mark

2026 | IAA Journal of Scientific Research | Pp. 71-77

Malaria during pregnancy constituted a major public health challenge in endemic regions, causing maternal anemia, placental infection, low birth weight, and increased perinatal mortality. Pregnant women exhibit increased susceptibility due to immunological ch...

2026 School of Pharmacy

Dual GLP-1/GIP Agonists for Weight Reduction and Cardiovascular Outcomes in Type 2 Diabetes

Ernest Nsubuga

2026 | IAA Journal of Scientific Research | Pp. 65-70

Type 2 diabetes mellitus (T2DM) was characterized by hyperglycemia and frequently accompanied by obesity and elevated cardiovascular risk. Incretin hormone-based therapies, especially glucagon-like peptide-1 receptor agonists (GLP-1 RAs), had demonstrated eff...

2026 School of Pharmacy

Dual GIP/GLP-1 Receptor Agonists for Type 2 Diabetes: Efficacy and Metabolic Benefits

Ernest Nsubuga

2026 | IAA Journal of Scientific Research | Pp. 55-64

Type 2 diabetes mellitus represented a global metabolic crisis characterized by progressive beta cell dysfunction, insulin resistance, and chronic hyperglycemia. Traditional incretin-based therapies targeting glucagon-like peptide 1 (GLP-1) receptors have dem...